A key Food and Drug Administration advisory panel will review and vote on Johnson & Johnson’s one-time Covid-19 vaccine Friday, potentially paving the way for an emergency use authorization in the coming days. If authorized, J & J’s injection would be the third to be made available in the US and distributed through a relatively simple supply chain: the single-dose regimen eliminates the need to monitor repeat visits, and the drug can be used at less extreme temperatures. are preserved than vaccines made by Pfizer and Moderna. The influx of supply and simplified logistics would likely mean an immediate rise in national vaccination coverage when the vaccine hits the market next week.
The US records at least 73,300 new Covid-19 cases and at least 2,160 virus-related deaths every day, based on a seven-day average calculated by CNBC based on data from Johns Hopkins University.
The following data was collected by Johns Hopkins University:
- Worldwide cases: more than 113.08 million
- Worldwide deaths: At least 2.5 million
- US cases: more than 28.41 million
- Deaths in the US: at least 508,314